Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD and PEA for Painful Diabetic Peripheral Neuropathy
NCT05766969Phase 2Unknown
- Sponsor
- Pure Green Pharmaceuticals
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol, palmitoylethanolamide in diabetic peripheral neuropathy (DPN), sponsored by Pure Green Pharmaceuticals. Status: unknown.
02
Drugs
cannabidiolpalmitoylethanolamide
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT05766969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05766969.